Whole Blood

Bladder Cancer Whole Blood - Sanguine Biosciences, Inc

Bladder Cancer Whole Blood

Bladder Cancer Whole Blood samples are obtained from donors with clinically diagnosed bladder cancer. Valuable for genomic studies, immune cell characterization, and evaluating host-tumor interactions.

Breast Cancer Whole Blood

Breast Cancer Whole Blood

Fresh Breast Cancer Whole Blood – IRB-consented breast cancer whole blood samples collected from donors diagnosed with breast cancer. Ideal identifying early detection biomarkers and understanding disease progression.

Cervical Cancer Whole Blood - Sanguine Biosciences, Inc

Cervical Cancer Whole Blood

Cervical Cancer Whole Blood samples are obtained from donors with clinically diagnosed cervical cancer. Valuable for comprehensive immune profiling, host genetic analysis, and monitoring systemic immune alterations.

Colorectal Cancer Whole Blood - Sanguine Biosciences, Inc

Colorectal Cancer Whole Blood

Colorectal Cancer Whole Blood samples are obtained from donors with clinically diagnosed colorectal cancer. Valuable for genomic studies, immune cell profiling, and integrative analyses of host-tumor dynamics.

Essential Thrombocythemia Whole Blood

Essential Thrombocythemia Whole Blood

Essential Thrombocythemia Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Essential Thrombocythemia (ET). Ideal for dermatology, immunology, and inflammation-based research.

Graft-Versus-Host Disease Whole Blood - Sanguine Biosciences, Inc

Graft-Versus-Host Disease Whole Blood

Graft-versus-Host Disease Whole Blood samples are obtained from donors with clinically diagnosed graft-versus-host disease (GVHD). Valuable for gene expression studies, immune cell profiling, and identifying molecular pathways involved in transplant-related complications.

Hepatocellular Carcinoma Whole Blood - Sanguine Biosciences, Inc

Hepatocellular Carcinoma Whole Blood

Hepatocellular Carcinoma Whole Blood samples are obtained from donors with clinically diagnosed hepatocellular carcinoma (HCC). Valuable for genomic and transcriptomic analysis, immune profiling, and identifying systemic factors contributing to liver tumor development.

Kidney Cancer Whole Blood - Sanguine Biosciences, Inc

Kidney Cancer Whole Blood

Kidney Cancer Whole Blood samples are obtained from donors with clinically diagnosed kidney cancer. Valuable for transcriptomic studies, immune profiling, and identifying genomic and epigenetic alterations associated with renal malignancy.

Leukemia Whole Blood

Leukemia Whole Blood

Leukemia Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Leukemia. Ideal for dermatology, immunology, and inflammation-based research.

Lung Cancer Whole Blood

Lung Cancer Whole Blood

Lung Cancer Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Lung Cancer. Ideal for oncology, immunology, and inflammation-based research.

Lymphoma Whole Blood

Lymphoma Whole Blood

Lymphoma Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Lymphoma. Ideal for dermatology, immunology, and inflammation-based research.

Melanoma Whole Blood

Melanoma Whole Blood

Melanoma Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Melanoma. Ideal for dermatology, immunology, and inflammation-based research.

Myelodysplastic Syndrome Whole Blood - Sanguine Biosciences, Inc

Myelodysplastic Syndrome Whole Blood

Myelodysplastic Syndrome Whole Blood samples are obtained from donors with clinically diagnosed Myelodysplastic Syndrome (MDS). Valuable for genetic and transcriptomic studies, mutational profiling (e.g., TP53, SF3B1), and evaluating immune and hematologic abnormalities in clonal myeloid disorders.

Myeloproliferative Neoplasm Whole Blood - Sanguine Biosciences, Inc.

Myeloproliferative Neoplasm Whole Blood

Myeloproliferative Neoplasm Whole Blood samples are obtained from donors with clinically diagnosed myeloproliferative neoplasm (MPN). Valuable for genomic and transcriptomic studies, mutational analysis (e.g., JAK2, CALR, MPL), and immune cell profiling in clonal hematologic disorders.

Ovarian Cancer Whole Blood

Ovarian Cancer Whole Blood

Ovarian Cancer Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Ovarian Cancer. Ideal for oncology, immunology, and inflammation-based research.

Pancreatic Cancer Whole Blood - Sanguine Biosciences, Inc

Pancreatic Cancer Whole Blood

Pancreatic Cancer Whole Blood samples are obtained from donors with clinically diagnosed Pancreatic Cancer (PC). Valuable for genomic and transcriptomic analysis, immune profiling, and detecting molecular alterations driving PC development and therapeutic resistance.

Polycythemia Vera Whole Blood - Sanguine Biosciences, Inc

Polycythemia Vera Whole Blood

Polycythemia Vera Whole Blood samples are obtained from donors with clinically diagnosed Polycythemia Vera (PV). Valuable for genomic and transcriptomic analysis, JAK2 mutation detection, and immune profiling in this chronic myeloproliferative neoplasm.

Prostate Cancer Whole Blood- Sanguine Biosciences

Prostate Cancer Whole Blood

Prostate Cancer Whole Blood samples are obtained from donors with clinically diagnosed Prostate Cancer (PCa). Valuable for transcriptomic and genomic studies, immune profiling, and identifying molecular alterations driving PCa pathogenesis.

Renal Cell Carcinoma Whole Blood - Sanguine Biosciences

Renal Cell Carcinoma Whole Blood

Renal Cell Carcinoma Whole Blood samples are obtained from donors with clinically diagnosed Renal Cell Carcinoma (RCC). Valuable for transcriptomic and genomic studies, immune profiling, and identification of molecular alterations driving RCC pathogenesis and treatment resistance.

Sarcoma Whole Blood - Sanguine Biosciences

Sarcoma Whole Blood

Sarcoma Whole Blood samples are obtained from donors with clinically diagnosed Sarcoma. Valuable for genomic and transcriptomic studies, immune profiling, and investigating the systemic molecular signatures underlying sarcoma development and therapeutic resistance.